Luke Burman

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 3

Top Topics

High Throughput Sequencing

Cancer Stem Cells

Capillary Electrophoresis

Top Venues

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Zhiwen Xu, Hira Lal Goel, Christoph Burkart, Luke Burman, Yeeting E Chong, Alison G Barber, Yanyan Geng, Liting Zhai, Mengdie Wang, Ayush Kumar, Ann Menefee, Clara Polizzi, Lisa Eide, Kaitlyn Rauch, Justin Rahman, Kristina Hamel, Zachary Fogassy, Sofia Klopp-Savino, Suzanne Paz, Mingjie Zhang, Andrea Cubitt, Leslie A Nangle, Arthur M Mercurio
Inhibition of VEGF binding to neuropilin-2 enhances chemosensitivity and inhibits metastasis in triple-negative breast cancer. Science translational medicine 15 (694) (2023)
Zhiwen Xu, Hira Lal Goel, Christoph Burkart, Luke Burman, Yeeting E Chong, Alison G Barber, Yanyan Geng, Liting Zhai, Mengdie Wang, Ayush Kumar, Ann Menefee, Clara Polizzi, Lisa Eide, Kaitlyn Rauch, Justin Rahman, Kristina Hamel, Zachary Fogassy, Sofia Klopp-Savino, Suzanne Paz, Mingjie Zhang, Andrea Cubitt, Leslie A Nangle, Arthur M Mercurio
Inhibition of VEGF binding to neuropilin-2 enhances chemosensitivity and inhibits metastasis in triple-negative breast cancer. Science translational medicine 15 (694) (2023)
Luke Burman, Yeeting E Chong, Sherie Duncan, Anders Klaus, Kaitlyn Rauch, Kristina Hamel, Karine Hervé, Stephanie Pfaffen, David W Collins, Kevin Heyries, Leslie Nangle, Carl Hansen, David J King
Isolation of monoclonal antibodies from anti-synthetase syndrome patients and affinity maturation by recombination of independent somatic variants. mAbs 12 (1) (2021)